Overview
Jonathan Shammash is a primary care provider, practicing in Internal Medicine in Hackensack, New Jersey.
His clinical expertise encompasses Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, and Secondary Systemic Amyloidosis.
Dr. Shammash is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 3 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
385 Prospect Avenue, Suite 204, Hackensack, NJ 7601.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Vivian & Seymour Milstein Family Heart Center
Mathew S. Maurer, MD - Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus. He is the Director of the Cardiac Amyloidosis Program. He has published over 300 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults. Dr. Maurer is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Maurer is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure And Transplant Cardiology. Dr. Maurer is currently accepting new patients.
NewYork Presbyterian Columbia University Irving Medical Center
John Bilezikian is an Internal Medicine provider practicing medicine in New York, New York. Dr. Bilezikian is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Hypoparathyroidism, Hypercalcemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
Orthopedic Specialist Group
Marco Tartaglia is a primary care provider, practicing in Internal Medicine in Bloomfield, New Jersey. Dr. Tartaglia is highly rated in 59 conditions, according to our data. His clinical expertise encompasses RASopathies, Noonan Syndrome, Rommen Mueller Sybert Syndrome, and Cardiomyopathic Lentiginosis.
Frequently Asked Questions about Dr. Jonathan B. Shammash
How do I make an appointment with Dr. Jonathan B. Shammash?
You can book an appointment with Dr. Jonathan B. Shammash by calling their office at 551-996-9150. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jonathan B. Shammash a top-rated expert for Atypical Hemolytic Uremic Syndrome (aHUS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jonathan B. Shammash is classified as an Experienced expert for Atypical Hemolytic Uremic Syndrome (aHUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jonathan B. Shammash specialize in?
While Dr. Jonathan B. Shammash is a Internal Medicine, they have specific expertise in Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, and D-Plus Hemolytic Uremic Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Jonathan B. Shammash participate in research or clinical trials?
Yes. Dr. Jonathan B. Shammash has published 3 articles and abstracts on conditions like Atypical Hemolytic Uremic Syndrome (aHUS). You can view a list of Dr. Jonathan B. Shammash's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jonathan B. Shammash accept my insurance?
Dr. Jonathan B. Shammash accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 551-996-9150 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Shammash isExperienced. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
- D-Plus Hemolytic Uremic SyndromeDr. Shammash isExperienced. Learn about D-Plus Hemolytic Uremic Syndrome.
- DysgraphiaDr. Shammash isExperienced. Learn about Dysgraphia.
- Familial HypertensionDr. Shammash isExperienced. Learn about Familial Hypertension.
- Familial Hypocalciuric Hypercalcemia Type 1Dr. Shammash isExperienced. Learn about Familial Hypocalciuric Hypercalcemia Type 1.
- GlomerulonephritisDr. Shammash isExperienced. Learn about Glomerulonephritis.